PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ

Ceren AKAL, (Ankara Üniversitesi, Ziraat Fakültesi, Süt Teknolojisi Bölümü, Ankara, Türkiye)
Atila YETİŞEMİYEN (Ankara Üniversitesi, Ziraat Fakültesi, Süt Teknolojisi Bölümü, Ankara, Türkiye)
GIDA
66 6
Yıl: 2020 Cilt: 45 Sayı: 2 Sayfa Aralığı: 380 - 389 Metin Dili: Türkçe DOI: 10.15237/gida.GD20016 İndeks Tarihi: 09-02-2021

PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ

Öz:
Dünya genelinde yüksek oranda görülen laktaz yetersizliğinin tedavi edilmesi veya sebep olduğu olumsuzetkilerin azaltılması üzerine uzun yıllardır çok sayıda çalışma yapılmıştır. Süt tüketiminin mecburenazaltılmasına neden olan laktaz yetersizliğinin temelde genetik faktörlere dayanması, bu rahatsızlığınönlenmesine engel olmaktadır. Ancak önlenemese de süt tüketimine imkan tanıyacak kadar ortaya çıkanrahatsızlıkların kontrol altına alınması mümkündür. Bu nedenle daha çok bu etkileri azaltmaya yönelikalternatif çözümler aranmaktadır. Son yıllarda yapılan araştırmalar, bu amaçla probiyotik ve prebiyotiktüketiminin laktoz intoleransına sahip kişilerde laktaz yetersizliğine bağlı olarak görülen etkileri azalttığınıgöstermiştir. Bu çalışma kapsamında laktoz intoleransı üzerine probiyotik ve prebiyotik kullanımının etkileriüzerine yapılan araştırmalar incelenmiştir.
Anahtar Kelime:

THE EFFECTS OF PROBIOTIC AND PREBIOTIC CONSUMPTION ON LACTOSE INTOLERANCE

Öz:
For many years, different studies have been conducted on the treatment or reducing the harmful effects of lactase deficiency, which is prevailing all around the world. Lactase deficiency, which causes to reduce milk consumption, is mainly based on genetic factors, and they inhibit the prevention of this disease. However, even if it cannot be prevented, it is possible to control the disorders that occur to allow milk consumption. Therefore, alternative methods are being sought to reduce these effects. Recent studies have shown that probiotics and prebiotic consumption reduces the impacts of lactase deficiency in people with lactose intolerance. This paper reviews the studies on the effects of probiotic and prebiotic use on lactose intolerance.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Almeida, C.C., Lorena, S.L.S., Pavan, C.R., Akasaka, H.M.I., Mesquita, M.A. (2012). Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei shirota and Bifidobacterium breve yakult may persist after suspension of therapy in lactose-intolerant patients. Nutr Clin Pract, 27: 247–251.
  • Amiri, M., Diekmann, L., von KöckritzBlickwede, M., Naim, H.Y. (2015). The Diverse Forms of Lactose Intolerance and the Putative Linkage to Several Cancers. Nutrients, 7: 7209- 7230, doi:10.3390/nu7095332.
  • Arnold, J.W., Simpson, J.B., Roach, J., BrunoBarcena, J.M., Azacarate-Peril, M.A. (2018). Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus. Nutrients, 10: 1517. doi:10.3390/nu10101517.
  • Azcarate-Peril, M.A., Ritter, A.J., Savaiano, D., Monteagudo-Mera, A., Anderson, C., Magness, S.T., Klaenhammer, T.R. (2017). Impact of shortchain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci, 114, E367-E375.
  • Bakken, T., Braaten, T., Olsen, A., Hjartåker, A., Lund, E., Skeie, G. (2018). Milk and risk of colorectal, colon and rectal cancer in the Norwegian Women and Cancer (NOWAC) Cohort Study. Br J Nutr, 119: 1274-1285.
  • Barrubes, L., Babio N., Mena-Sanchez G., Toledo E., Ramirez-Sabio J.B., Estruch, R., Ros, E., Fito, M., Aros, F., Fiol, M., Santos-Lozana, J., SerraMajem, L., Pinto, X., Martınez-Gonzalez, M. A., Sorli, J. V., Basora, J., Salas-Salvado, J. (2018). Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk. Int J Cancer, 143: 1356– 1366.
  • Bayhan, A. ve Yentür G. (1993). Laktoz İntoleransı. Gıda, 18(6): 385-388. Bayless, T. M., Brown, E., Paige, D. M. (2017). Lactase Non-persistence and Lactose Intolerance. Curr Gastroenterol Rep, 19:23. DOI:10.1007/s11894-017-0558-9.
  • Cano‐Contreras, A.D., Pérez y López, N.J., Minero‐Alfaro I., Medina‐López; V.M., Reyes‐ Huerta. J. U. (2019). Efficacy of probiotic I3.1 symptomatic improvement in patients with lactose intolerance. Abstracts of the 18th American Neurogastroenterology and Motility Society Annual Scientific Meeting, 16-18 August, Chicago, Illinois, USA.
  • Corgneau, M.M., Scher, J., Ritie-Pertusa, L., Le D.T.L., Petit, J., Nikolova, Y., Banon, S., Gaiani, C. (2017). Recent advances on lactose intolerance: Tolerance thresholds and currently available answers, Crit Rev Food Sci Nutr, 57:15, 3344-3356, DOI:10.1080/10408398.2015.1123671.
  • Costanzo, D. M., Canani, R. B. (2018). Lactose intolerance: Common misunderstandings. Ann Nutr Metab, 73 (suppl 4):30-37.
  • Däbritz, J., Mühlbauer, M., Domagk, D., Voos, N., Henneböhl, G., Siemer, M.L., Foell, D. (2014). Significance of hydrogen breath tests in children with suspected carbohydrate malabsorption. BMC Pediatr, 14. doi: 10.1186/1471-2431-14-59.
  • Demirgül, F. ve Demirgül R. (2019). Laktoz intoleransın prevalansı, teşhisi ve laktozsuz beslenme tavsiyeleri. Food and Health, 5(4), 281- 290. https://doi.org/10.3153/FH19028.
  • Dhama, K., Latheef, S. K. and Munjal A. K. (2016). Probiotics in curing allergic and inflammatory conditions – Research progress and futuristic vision. Recent Pat Inflamm Allergy Drug Discov, 10 (1):21-33.
  • Domínguez-Jiménez, J.L., Fernández-Suárez, A. (2017). Diagnosis of lactose intolerance. Med Clin, 148(6):262-264.
  • Fassio, F., Facioni, M. S., Guagnini, F. (2018). Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on Current Management and Future Perspectives. Nutrients, 10: 1599; doi:10.3390/nu10111599.
  • Forsgård, R. A. (2019). Lactose digestion in humans: intestinal lactase appears to be constitutive whereas the colonic microbiome is adaptable. Am J Clin Nutr, 110:273-279.
  • Fox, P.F., Uniacke-Lowe, T., McSweeney, P.L.H. and O’Mahony, J.A.M. (2015). Lactose. In: Dairy Chemistry and Biochemistry, 21–68. Springer International Publishing, Cham.
  • Ganesan, K., Chung, S. K., Vanamala, J., Xu, B. (2018). Causal Relationship between DietInduced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes. Int J Mol Sci, 19: 3720. doi:10.3390/ijms19123720
  • Gingold-Belfer, R., Levy, S., Layfer, O., Pakanaev, L., Niv, Y., Dickman, R., Parets, T. T. (2019). Use of a Novel Probiotic Formulation to Alleviate Lactose Intolerance Symptoms—a Pilot Study. Probiotics Antimicrob Proteins, Jan 7. https://doi.org/10.1007/s12602-018-9507-7.
  • Hajare, S.T., Bekele, G. (2017). Effect of probiotic strain Lactobacillus acidophilus (LBKV-3) on fecal residual lactase activity in undernourished children below 10 years. J Immunoass Immunoch, 38(6): 620-628.
  • Harvey, L., Ludwig, T., Hou, A. Q., Hock, Q. S., Tan, M. L. N., Osatakul, S., Bindels, J., Muhardi, L. (2018). Prevalence, cause and diagnosis of lactose intolerance in children aged 1–5 years: a systematic review of 1995–2015 literature. Asia Pac J Clin Nutr, 27(1):29-46.
  • He, T., Priebe, M.G., Harmsen, H.J.M., Stellaard, F., Sun, X., Welling, G.W., Vonk, R.J. (2006). Colonic fermentation may play a role in lactose intolerance in humans. J Nutr, 136(1): 58-63.
  • He, T., Priebe, M. G., Zhong, Y., Huang, C., Harmsen, H. J. M., Raangs, G. C., Antoine, J. M., Welling, G. W., Vonk, R. J. (2008). Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J Appl Microbiol, 104: 595–604. doi:10.1111/j.1365-2672.2007.03579.x
  • Hegar, B., Widodo A. (2015). Lactose intolerance in Indonesian children. Asia Pac J Clin Nutr, 215, 24(Suppl 1):S31-40. doi: 10.6133/apjcn.2015.24. s1.06.
  • Kim, J.W. (2017). Lactose intolerance and colorectal cancer. Ann Coloproctol, 33(5):157-158. Kleniewska, P., Hoffmann, A., Pniewska, E., Pawliczak, R. (2016). The Influence of Probiotic Lactobacillus casei in combination with prebiotic ınulin on the antioxidant capacity of human plasma. Oxid Med Cell Longev, 2016:1340903.
  • Latorre, G., Besa, P., Parodi, C.G., Ferrer, V., Azocar, L., Quirola, M. and Chianale, J. (2014). Prevalence of lactose intolerance in Chile: a double-blind placebo study. Digestion, 90(1): 18- 26.
  • Liu, F., Li, P., Chen, M., Luo, Y., Prabhakar, M., Zheng, H., He, Y., Qi, Q., Long, H., Zhang, Y., Sheng, H., Zhou, H. (2017). Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase Bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population. Sci Rep, 7: 11789.
  • Ma, J., Giovannucci, E., Pollak, M., Chan, J. M., Gaziano, J. M., Willett, W., Stampfer, M. J. (2001). Milk intake, circulating levels of insulin-like growth factor-1, and risk of colorectal cancer in men. J Natl Cancer Inst, 93: 1330-1336.
  • Mahboubi, M., Kazempour, N. (2016). The effects of inulin on characteristics of Lactobacillus paracasei TD3 (IBRC-M 10784) as probiotic bacteria in vitro. Arch Iran Med, 19(2): 92-95.
  • Melini, F., Melini, V., Luziatelli, F., Ficca, A. G., Ruzzi, M. (2019). Health-promoting components in fermented foods: An up-to-date systematic review. Nutrients, 11: 1189.
  • Metin, M. (2005). Süt Teknolojisi Sütün bileşimi ve işlenmesi. Ege Üniversitesi Basımevi, İzmir, 802 s. Moens, F., Weckx, S., Vuyst, L. D. (2016). Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii. Int J Food Microbiol, 231: 76-85.
  • Minale, P., Hiller, J., Kramer, M. F., Heath, M., Justicia, J. L. (2019). Symbiotics as a new perspective in the treatment of lactose intolerance. Ann Nutr Metab, 74(suppl 1):1-31.
  • Muñoz-Tamayo, R., Laroche, B., Walter, E., Doré, J., Duncan, S.H., Flint, H.J., Leclerc, M. (2011). Kinetic Modelling of lactate utilization and butyrate production by key human colonic bacterial species. FEMS Microbiol Ecol, 76(3):615- 624.
  • Mustapha, A., Jiang, T., Savaiano, D.A. (1997). Improvement of lactose digestion by humans following ingestion of unfermented acidophilus milk: influence of bile sensitivity, lactose transport, and acid tolerance of Lactobacillus acidophilus. J Dairy Sci, 80:1537-1545.
  • Noble, S., Rawlinson, F. and Byrne, A. (2002). Acquired lactose intolerance: A seldom considered cause of diarrhea in the palliative care setting. J Pain Symptom Manag, 23: 449-508.
  • Oak, S. J. ve Jha, R. (2019) The effects of probiotics in lactose intolerance: A systematic review. Crit Rev Food Sci Nutr, 59 (11): 1675-1683.
  • Ozturkoglu-Budak, S., Akal, H.C., Buran, İ., Yetişemiyen, A. (2019). Effect of inulin polymerization degree on various properties of synbiotic fermented milk including Lactobacillus acidophilus La-5 and Bifidobacterium animalis Bb-12. J Dairy Sci, 102(8): 6901-6913
  • Pakdaman, M.N., Udani, J.K., Molina, J.P., Shahani, M. (2016). The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance: a randomized, double-blind, placebo-controlled, crossover clinical trial. Nutr J, 15 (1):56.
  • Pawłowska, K., Umławska, W. and Iwanczak, B. (2015). Prevalence of lactose malabsorption and lactose intolerance in pediatric patients with selected gastrointestinal diseases. Adv Clin Exp Med, 24 (5): 863-871.
  • Perna, A., Intaglietta, I., Simonetti, A., Gambacorta, E. (2015). Donkey milk for manufacture of novel functional fermented beverages. J Food Sci, 80: 1352-1359.
  • Ritter, A.J., Chey, W.D., Foyt, H.L., Sandborn, W.J., Savaiano, D.A. (2018). Improvement of clinical symptoms of lactose intolerance with a novel prebiotic galacto-oligosaccharide, RP-G28. AGA Abstracts, 154(6-1):1047.
  • Roškar, I., Švigelj, K., Štempelj, M., Volfand, J., Štabuc, B., Malovrh, Š., Rogelj, I. (2017). Effects of a probiotic product containing Bifidobacterium animalis subsp. animalis IM386 and Lactobacillus plantarum MP2026 in lactose intolerant individuals: Randomized, placebo-controlled clinical trial. J Funct Foods, 35: 1-8.
  • Santos, G. J., Rocha, R., Santana, G. O. (2019). Lactose intolerance: what is a correct management? Rev Assoc Med Bras, 65(2):270-275.
  • Savaiano, D.A., Ritter, A.J., Klaenhammer, T.R., James, G.M., Longcore, A.T., Chandler, J.R., Walker, W.A., Foyt, H.L. (2013). Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): A randomized, double-blind clinical trial. Nutr J, 12:160.
  • Sharifi-Zahabi, E., Abdollahzad,, H., Nachvak,, S.M., Pasdar, Y., Bagheri, A., Sahargahi, B., Mahaki, B. (2018). Prevalence of lactose intolerance and its association with breakfast consumption in Iranian adolescents. Nutr Food Sci, 49(1): 170-178.
  • Staudacher, H. (2015). Probiotics for lactose intolerance and irritable bowel syndrome. Br J Community Nurs, June/July: 12-14.
  • Swallow, D.M. (2003). Genetics of lactase persistence and lactose intolerance. Annu Rev Genet, 37:197-219.
  • Szilagyi, A., Ishayek, N. (2018). Lactose Intolerance, Dairy Avoidance, and Treatment Options. Nutrients, 10: 1-30. doi:10.3390/nu10121994
  • Thongaram, T., Hoeflinger, J.L., Chow, J., Miller, M.J. (2017). Prebiotic galactooligosaccharide metabolism by probiotic lactobacilli and bifidobacteria. J Agric Food Chem, 65: 4184-4192.
  • Usai-Satta, P., Scarpa, M., Oppia, F., Cabras, F. (2012). Lactose malabsorption and intolerance: What should be the best clinical management? World J Gastrointest Pharmacol Ther, 3(3): 29-33.
  • Ugidos-Rodríguez, S., Matallana-González, M.C., Sánchez-Mata, M.C. (2018). Lactose malabsorption and intolerance: a review. Food Funct, 9: 4056- 4068.
  • Uymaz, B. (2010). Probiyotikler ve Kullanım alanları. Pamukkale Univ Müh Bilim Derg, 16 (1): 95- 104.
  • Vitellio, P., Celano, G., Bonfrate, L., Gobbetti, M., Portincasa, P., Angelis, M.D. (2019). Effects of Bifidobacterium longum and Lactobacillus rhamnosus on gut microbiota in patients with lactose intolerance and persisting functional gastrointestinal symptoms: A randomised, double-blind, cross-over study. Nutrients, 11: 886. doi:10.3390/nu11040886.
  • Vonk, R.J., Reckman, G.A.R., Harmsen, H.J.M., Priebe, M.G. (2012). Probiotics and Lactose Intolerance. In: Probiotics, IntechOpen, doi: 10.5772/51424.
  • WCRFI/AICR (World Cancer Research Fund International/American Institute for Cancer Research). (2017). Continuous Update Project Report. Diet, Nutrition, Physical Activity and Colorectal Cancer. WCRF Network. London/Washington, DC.
  • Zheng, X., Chu, H., Cong, Y., Deng, Y., Long, Y., Zhu, Y. and Fox, M. (2015). Self-reported lactose intolerance in clinic patients with functional gastrointestinal symptoms: prevalence, risk factors, and impact on food choices. J Neurogastroenterol Motil, 27(8): 1138-1146.
APA AKAL C, YETISEMIYEN A (2020). PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. , 380 - 389. 10.15237/gida.GD20016
Chicago AKAL Ceren,YETISEMIYEN ATILA PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. (2020): 380 - 389. 10.15237/gida.GD20016
MLA AKAL Ceren,YETISEMIYEN ATILA PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. , 2020, ss.380 - 389. 10.15237/gida.GD20016
AMA AKAL C,YETISEMIYEN A PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. . 2020; 380 - 389. 10.15237/gida.GD20016
Vancouver AKAL C,YETISEMIYEN A PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. . 2020; 380 - 389. 10.15237/gida.GD20016
IEEE AKAL C,YETISEMIYEN A "PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ." , ss.380 - 389, 2020. 10.15237/gida.GD20016
ISNAD AKAL, Ceren - YETISEMIYEN, ATILA. "PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ". (2020), 380-389. https://doi.org/10.15237/gida.GD20016
APA AKAL C, YETISEMIYEN A (2020). PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. GIDA, 45(2), 380 - 389. 10.15237/gida.GD20016
Chicago AKAL Ceren,YETISEMIYEN ATILA PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. GIDA 45, no.2 (2020): 380 - 389. 10.15237/gida.GD20016
MLA AKAL Ceren,YETISEMIYEN ATILA PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. GIDA, vol.45, no.2, 2020, ss.380 - 389. 10.15237/gida.GD20016
AMA AKAL C,YETISEMIYEN A PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. GIDA. 2020; 45(2): 380 - 389. 10.15237/gida.GD20016
Vancouver AKAL C,YETISEMIYEN A PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ. GIDA. 2020; 45(2): 380 - 389. 10.15237/gida.GD20016
IEEE AKAL C,YETISEMIYEN A "PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ." GIDA, 45, ss.380 - 389, 2020. 10.15237/gida.GD20016
ISNAD AKAL, Ceren - YETISEMIYEN, ATILA. "PROBİYOTİK VE PREBİYOTİK TÜKETİMİNİN LAKTOZ İNTOLERANSI ÜZERİNE ETKİLERİ". GIDA 45/2 (2020), 380-389. https://doi.org/10.15237/gida.GD20016
Sayfa Oluşturulma Tarihi
07-05-2024 11:50

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları